Phase 3 trials may be just as fast...If Phase 2 was designed well ,they could have a lot of data already...
What would be better, is an announcement that phase2 is to be extended into a Phase 3, by expansion..
And say this was because the results are so good. It's a good feeling doing trials that we know the results of in advance.
If there were any problems with any of the 5000 procedures done so far, the company would have had to disclose it. So authorities and regulators in Europe are not seeing any adverse reactions or side effects..
Another company that is now derisked, cash and technology are all good.
a feasibility study of the recell® autologous , page-4
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.84 |
Change
-0.120(3.03%) |
Mkt cap ! $268.3M | |||
| Open | High | Low | Value | Volume |
| $3.94 | $3.94 | $3.76 | $511.0K | 134.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.84 | 11883 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |